IMPORTANT MESSAGE: The 2014-2019 phase of the HHQI National Campaign concluded on July 17, 2019. Click here for details.
COVID-19: For the latest updates and information on the COVID-19 pandemic, please visit the Quality Insights website.

Mitigating Cardiovascular Healthcare Disparities

New Guidelines for Cholesterol Treatment

March 20, 2014  |  Download Handouts  |  Playback Recording (60 min)

Cardiovascular disease (CVD) represents the largest health burden to the American public despite substantial reductions in death rates since 1960. Atherosclerotic CVD is the major component of CVD.

In this 60-minute webinar, attendees will learn to:

  1. Identify and overcome obstacles to effective, equal treatment of atherosclerotic cardiovascular risk and disease.
  2. Understand and apply new 2013 ACC/AHA Cholesterol treatment guidelines.
  3. Enable patients and providers to discuss treatment goals.
  4. Improve provider adherence to treatment guidelines and improve patient adherence to medical regimen and thus reduce/eliminate cardiovascular healthcare disparities.
Patrice Desvigne-Nickens, M.D.Guest Speaker:
Patrice Desvigne-Nickens, M.D.
Medical Officer, Division of Cardiovascular Sciences
National Heart, Lung, and Blood Institute (NHLBI)

Patrice Desvigne-Nickens, M.D., is a medical officer in the Heart Failure and Arrhythmias Branch at the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH). Dr. Desvigne-Nickens is an experienced clinical trialist and is the project officer for The Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglycerides: Impact on Global Health (AIM-HIGH). Dr. Nickens has managed trials in acute coronary syndromes, heart failure, diabetes and revascularization, cardiac surgery, and use of left ventricular assist devices in advanced heart failure. She is particularly interested in disparities in the practice of medicine and cardiovascular health.

This free webinar is presented by:

Home Health Quality Improvement (HHQI) National Campaign

National Heart, Lung, and Blood Institute (NHLBI)